Use of sulfamate derivatives for treating impulse control disorders
CA 2364949 A1 · Owner: University Of Cincinnati · Inventors: Mcelroy, Susan L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Impulse Control Disorders (ICDs) are characterized by harmful behaviors performed in response to irresistible impulses. The essential feature of an ICD is the failure to resist an impulse drive, or temptation and to perform , an act that is harmful to the person or to others. The present invention comprises methods for the treatment or prevention of ICDs using a class of sulfamates of formula (I) wherein X is CH2 or oxygen and R1, R2, R3, R4 and , R5 are as herein defined. Further pharmaceutical compositions containing a compound of formula (I) as well as methods for their use and intermediates form part of the present invention are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.